NADPH oxidase 5 (NOX5) mRNA (NOX5 mRNA)

NADPH oxidase 5 (NOX5) mRNA is the transcript encoding the NOX5 enzyme, a unique member of the NADPH oxidase family that generates reactive oxygen species (ROS), specifically superoxide, in a calcium-dependent manner. Unlike other NOX isoforms, NOX5 does not require accessory proteins like p22phox for its activation, relying instead on its N-terminal EF-hand domains to sense intracellular calcium fluctuations. The mRNA and its protein product are highly expressed in various tissues, including the testis, spleen, and vascular system, where they play critical roles in signal transduction, cell proliferation, and vascular tone regulation. Dysregulation of NOX5 mRNA expression is linked to several pathologies, including hypertension, atherosclerosis, diabetic nephropathy, and various cancers, where excessive ROS production drives inflammation and tissue damage. Therapeutic strategies targeting NOX5 mRNA, such as small interfering RNAs (siRNAs), aim to silence the gene and reduce the enzymatic burden of oxidative stress. While small molecule inhibitors like Celastrol and Ebselen are also studied, the development of NOX5-specific therapies is challenged by the absence of the NOX5 gene in rodents, necessitating the use of humanized animal models for preclinical validation. Targeting the mRNA transcript offers a highly specific approach to modulating NOX5 activity compared to broad-spectrum antioxidants or non-selective NOX inhibitors. Monitoring NOX5 mRNA levels and downstream oxidative stress biomarkers is essential for evaluating the efficacy of these targeted interventions.

Other names

NOX5NADPH oxidase 5NOX5-SNOX5 transcript

Inhibition of superoxide production through gene silencing (RNA interference) or direct enzymatic inhibition, leading to reduced oxidative stress and modulation of redox-sensitive signaling pathways.